61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial
- 1 July 2017
- journal article
- research article
- Published by Elsevier in Brain Stimulation
- Vol. 10 (4) , 847-849
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trialWorld Psychiatry, 2015
- The State of US Health, 1990-2010JAMA, 2013
- TRANSCRANIAL MAGNETIC STIMULATION (TMS) FOR MAJOR DEPRESSION: A MULTISITE, NATURALISTIC, OBSERVATIONAL STUDY OF ACUTE TREATMENT OUTCOMES IN CLINICAL PRACTICEDepression and Anxiety, 2012
- Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depressionDepression and Anxiety, 2011
- Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive DisorderArchives of General Psychiatry, 2010
- Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive DisorderThe Journal of Clinical Psychiatry, 2008
- Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled TrialBiological Psychiatry, 2007
- Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D ReportAmerican Journal of Psychiatry, 2006
- The Epidemiology of Major Depressive DisorderJAMA, 2003
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960